Acetyl Hexapeptide-8 vs Argireline
A side-by-side research comparison of Acetyl Hexapeptide-8 and Argireline across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Acetyl Hexapeptide-8 | Argireline |
|---|---|---|
| Full name | Acetyl Hexapeptide-8 (Argireline Advanced) | Argireline (Acetyl Hexapeptide-3) |
| Category | Skin & Anti-Aging | Skin & Anti-Aging |
| Status | Research compound | Research compound |
| Mechanism | Same SNARE complex competition as argireline with acetyl modification for improved stability and cellular uptake. | Competes with SNAP-25 for position in SNARE complex, partially inhibiting vesicle docking and neurotransmitter release, reducing muscle contraction intensity. |
| Molecular weight | 889 Da | 889 Da |
| Half-life | 10-14 hours | 8-12 hours (topical) |
| Bioavailability | Improved (topical, acetylated) | Moderate (topical) |
| Typical dose | 5-10% | 5-10% solution |
| Frequency | 2x daily | 2x daily |
| Route | Topical | Topical |
Acetyl Hexapeptide-8 reported benefits
- Improved stability
- Expression wrinkle reduction
- Preventative anti-aging
- Compatible with most formulations
Argireline reported benefits
- Reduces expression wrinkles up to 30%
- Non-invasive Botox alternative
- Prevents new wrinkle formation
- No muscle paralysis
- Stackable with other peptides
Related comparisons
Research and educational reference only. Not medical advice.